Oncosil Medical Ltd (OSL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -197 | -58 | -6 | -54 |
| Investing Cash Flow | $-15 | $-197 | $-58 | $-6 | $-54 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -27 |
| Common Stock Issued | 12,781 | 6,428 | 9,675 | 9,316 | 260 |
| Other Financing Activity | -54 | -193 | -187 | -160 | -122 |
| Financing Cash Flow | $12,727 | $6,235 | $9,487 | $9,156 | $111 |
| Exchange Rate Effect | -41 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 4,501 | 9,394 | 11,280 | 12,240 | 20,998 |
| End Cash Position | 5,110 | 4,501 | 9,394 | 11,280 | 12,240 |
| Net Cash Flow | $649 | $-4,892 | $-1,886 | $-960 | $-8,758 |
| Free Cash Flow | |||||
| Capital Expenditure | -15 | -197 | -58 | -6 | -54 |
| Free Cash Flow | -15 | -197 | -58 | -6 | -54 |